Related Experiment Video
Updated: Jun 26, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Laparoscopic versus open simple prostatectomy: an evaluation of morbidity
T Casey McCullough1, Flavio L Heldwein, Shawn J Soon
1Division of Urology, Institut Mutualiste Montsouris, Paris, France. CaseyDO33@gmail.com
Journal of Endourology
|January 6, 2009
Summary
Laparoscopic simple prostatectomy (LSP) offers significant advantages over open simple prostatectomy (OSP) for benign prostatic hyperplasia management, including shorter catheterization and hospital stays, and fewer infections.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Surgical intervention is often necessary when medical therapy fails.
- Traditional open simple prostatectomy (OSP) has been the standard treatment.
Purpose of the Study:
- To compare the morbidity between laparoscopic simple prostatectomy (LSP) and open simple prostatectomy (OSP).
- To evaluate the efficacy of LSP versus OSP in managing benign prostatic hyperplasia.
Main Methods:
- A comparative study of 280 patients undergoing adenomectomy.
- Patients were divided into two groups: laparoscopic transcapsular (96 patients) and open transvesical (184 patients).
- Perioperative and outcome data were collected and analyzed.
Main Results:
- Laparoscopic simple prostatectomy (LSP) showed significantly shorter total catheter time (5.2 vs. 6.4 days) and hospital stay (6.3 vs. 7.7 days) compared to open simple prostatectomy (OSP).
- While operative time was longer for LSP (95.1 vs. 54.7 minutes), complication rates like hemorrhage were similar.
- Urinary tract infections and sepsis were significantly lower in the LSP group.
Conclusions:
- Laparoscopic simple prostatectomy (LSP) is associated with reduced postoperative morbidity compared to open simple prostatectomy (OSP).
- Key advantages of LSP include decreased catheter duration, shorter hospital stays, and fewer urinary tract infections.
- LSP represents a favorable alternative for benign prostatic hyperplasia management.
